A citation-based method for searching scientific literature

Musthafa Mohamed Essa, Marzieh Moghadas, Taher Ba-Omar, M Walid Qoronfleh, Gilles J Guillemin, Thamilarasan Manivasagam, Arokiasamy Justin-Thenmozhi, Bipul Ray, Abid Bhat, Saravana Babu Chidambaram, Amanda J Fernandes, Byoung-Joon Song, Mohammed Akbar. Neurotox Res 2019
Times Cited: 26







List of co-cited articles
168 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Huntington disease.
Gillian P Bates, Ray Dorsey, James F Gusella, Michael R Hayden, Chris Kay, Blair R Leavitt, Martha Nance, Christopher A Ross, Rachael I Scahill, Ronald Wetzel,[...]. Nat Rev Dis Primers 2015
682
15

Oxidative Stress in Neurodegenerative Diseases.
Ewa Niedzielska, Irena Smaga, Maciej Gawlik, Andrzej Moniczewski, Piotr Stankowicz, Joanna Pera, Małgorzata Filip. Mol Neurobiol 2016
357
15


Dendritic spines: Revisiting the physiological role.
Saravana Babu Chidambaram, A G Rathipriya, Srinivasa Rao Bolla, Abid Bhat, Bipul Ray, Arehally Marappa Mahalakshmi, Thamilarasan Manivasagam, Arokiasamy Justin Thenmozhi, Musthafa Mohamed Essa, Gilles J Guillemin,[...]. Prog Neuropsychopharmacol Biol Psychiatry 2019
97
11


A Metadata Analysis of Oxidative Stress Etiology in Preclinical Amyotrophic Lateral Sclerosis: Benefits of Antioxidant Therapy.
Leila Bond, Kamren Bernhardt, Priyank Madria, Katherine Sorrentino, Hailee Scelsi, Cassie S Mitchell. Front Neurosci 2018
34
11

Huntington's disease.
Francis O Walker. Lancet 2007
11

Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington's disease.
N Ahmad Aziz, Galia V Anguelova, Johan Marinus, Gert Jan Lammers, Raymund A C Roos. Parkinsonism Relat Disord 2010
101
11

Proteomic and oxidative stress analysis in human brain samples of Huntington disease.
Ma Alba Sorolla, Gemma Reverter-Branchat, Jordi Tamarit, Isidre Ferrer, Joaquim Ros, Elisa Cabiscol. Free Radic Biol Med 2008
201
11


Impaired Redox Signaling in Huntington's Disease: Therapeutic Implications.
Bindu D Paul, Solomon H Snyder. Front Mol Neurosci 2019
27
11

A Mitochondria-Associated Oxidative Stress Perspective on Huntington's Disease.
Ju Zheng, Joris Winderickx, Vanessa Franssens, Beidong Liu. Front Mol Neurosci 2018
42
11

Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration.
Libin Cui, Hyunkyung Jeong, Fran Borovecki, Christopher N Parkhurst, Naoko Tanese, Dimitri Krainc. Cell 2006
767
11

Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.
L A Raymond, V M André, C Cepeda, C M Gladding, A J Milnerwood, M S Levine. Neuroscience 2011
208
11


Proteins Containing Expanded Polyglutamine Tracts and Neurodegenerative Disease.
Adewale Adegbuyiro, Faezeh Sedighi, Albert W Pilkington, Sharon Groover, Justin Legleiter. Biochemistry 2017
72
7

Huntington's disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain.
U Rüb, K Seidel, H Heinsen, J P Vonsattel, W F den Dunnen, H W Korf. Brain Pathol 2016
72
7

Stroke rehabilitation.
Peter Langhorne, Julie Bernhardt, Gert Kwakkel. Lancet 2011
7

Apoptosis in neurodegenerative disorders.
M P Mattson. Nat Rev Mol Cell Biol 2000
7

Curcumin inhibits GPVI-mediated platelet activation by interfering with the kinase activity of Syk and the subsequent activation of PLCgamma2.
Azad Mayanglambam, Carol A Dangelmaier, Dafydd Thomas, C Damodar Reddy, James L Daniel, Satya P Kunapuli. Platelets 2010
25
8

Neuroprotective effects of curcumin.
Greg M Cole, Bruce Teter, Sally A Frautschy. Adv Exp Med Biol 2007
296
7

Anti-inflammatory effect of curcumin involves downregulation of MMP-9 in blood mononuclear cells.
K Saja, Mani Shankar Babu, D Karunagaran, P R Sudhakaran. Int Immunopharmacol 2007
45
7

Effect of curcumin on the adhesion of platelets to brain microvascular endothelial cells in vitro.
Li Zhang, Zhen-lun Gu, Zheng-hong Qin, Zhong-qin Liang. Acta Pharmacol Sin 2008
26
7

Protective effects of curcumin against ischaemia/reperfusion insult in rat forebrain.
Asser I Ghoneim, Ashraf B Abdel-Naim, Amani E Khalifa, Ezzeddin S El-Denshary. Pharmacol Res 2002
142
7

Matrix metalloproteinases in autism spectrum disorders.
Morsi W Abdallah, Tanja M Michel. J Mol Psychiatry 2013
29
7

Curcumin reduces amyloid fibrillation of prion protein and decreases reactive oxidative stress.
Chi-Fen Lin, Kun-Hua Yu, Cheng-Ping Jheng, Raymond Chung, Cheng-I Lee. Pathogens 2013
29
7

Curcumin as "Curecumin": from kitchen to clinic.
Ajay Goel, Ajaikumar B Kunnumakkara, Bharat B Aggarwal. Biochem Pharmacol 2008
7

Anti-ischemic effect of curcumin in rat brain.
Pradeep K Shukla, Vinay K Khanna, Mohd M Ali, Mohd Y Khan, Rikhab C Srimal. Neurochem Res 2008
91
7

Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin.
Panchanan Maiti, Jayeeta Manna, Shobi Veleri, Sally Frautschy. Biomed Res Int 2014
60
7

Therapeutic potential of curcumin for multiple sclerosis.
Munibah Qureshi, Ebtesam A Al-Suhaimi, Fazli Wahid, Omer Shehzad, Adeeb Shehzad. Neurol Sci 2018
45
7

Potential therapeutic and protective effect of curcumin against stroke in the male albino stroke-induced model rats.
Yuanyuan Zhang, Yi Yan, Yi Cao, Yongtao Yang, Qing Zhao, Rui Jing, Jiayi Hu, Juan Bao. Life Sci 2017
19
10

The prion protein and lipid rafts.
David R Taylor, Nigel M Hooper. Mol Membr Biol 2006
203
7

Spinal muscular atrophy.
Mitchell R Lunn, Ching H Wang. Lancet 2008
468
7

Prion disease: chemotherapeutic strategies.
Valerie L Sim. Infect Disord Drug Targets 2012
43
7

Mechanism of the Anti-inflammatory Effect of Curcumin: PPAR-gamma Activation.
Asha Jacob, Rongqian Wu, Mian Zhou, Ping Wang. PPAR Res 2007
138
7

Epigenetic modifications in trinucleotide repeat diseases.
Marguerite V Evans-Galea, Anthony J Hannan, Nissa Carrodus, Martin B Delatycki, Richard Saffery. Trends Mol Med 2013
32
7

Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer's disease Tg2576 mice.
Kwok Kin Cheng, Chin Fung Yeung, Shuk Wai Ho, Shing Fung Chow, Albert H L Chow, Larry Baum. AAPS J 2013
165
7

Inhibition of protease-resistant prion protein accumulation in vitro by curcumin.
Byron Caughey, Lynne D Raymond, Gregory J Raymond, Laura Maxson, Jay Silveira, Gerald S Baron. J Virol 2003
87
7

Curcumin and neurodegenerative diseases.
Adriana Monroy, Gordon J Lithgow, Silvestre Alavez. Biofactors 2013
91
7

PPARgamma agonist curcumin reduces the amyloid-beta-stimulated inflammatory responses in primary astrocytes.
Hong-Mei Wang, Yan-Xin Zhao, Shi Zhang, Gui-Dong Liu, Wen-Yan Kang, Hui-Dong Tang, Jian-Qing Ding, Sheng-Di Chen. J Alzheimers Dis 2010
99
7


Potential role of curcumin in stroke prevention.
Bruce Ovbiagele. Expert Rev Neurother 2008
19
10



Autism spectrum disorder: insights into convergent mechanisms from transcriptomics.
Mathieu Quesnel-Vallières, Robert J Weatheritt, Sabine P Cordes, Benjamin J Blencowe. Nat Rev Genet 2019
70
7


Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration.
Yin-Meng Tsai, Chao-Feng Chien, Lie-Chwen Lin, Tung-Hu Tsai. Int J Pharm 2011
296
7

Brain ischemia in patients with intracranial hemorrhage: pathophysiological reasoning for aggressive diagnostic management.
Daniel Naranjo, Michal Arkuszewski, Wojciech Rudzinski, Elias R Melhem, Jaroslaw Krejza. Neuroradiol J 2013
13
15


REVIEW: Curcumin and Alzheimer's disease.
Tsuyoshi Hamaguchi, Kenjiro Ono, Masahito Yamada. CNS Neurosci Ther 2010
223
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.